Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever

Shock

Volumn 26, Issue 1, 2006, Pages 10-12

  Fraunberger, Peter ^a   Wang, Ying ^a   Holler, Ernst ^b   Parhofer, Klaus G ^a   Nagel, Dorothea ^a   Walli, Autar K ^a   Seidel, Dietrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cytokines; Fever; Infection; Procalcitonin; Prognosis; Sepsis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; PREDICTIVE VALIDITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; ROC CURVE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; FEVER; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; ROC CURVE;

EID: 33747169897     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000215319.06866.bd     Document Type: Article

References (18)

1. O'Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J, Linden P, Maki DG, Nam M, Pasculle W et al: Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 26:392-408, 1998.
2. Circiumaru B, Baldock G, Cohen J: A prospective study of fever in the intensive care unit. Intensive Care Med 25:668-673, 1999.
3. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206-217, 2004.
4. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J, Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396-402, 2001.
5. Steinmetz HAT, Herbertz A, Bertram M, Diehl V: Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis. J Infect Dis 171:225-228, 1995.
6. LeMoine O, Deviere J, Devaster JM, Crusiaux A, Durand F, Bernuau J, Goldman M, Benhamou JP: Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 20:819-824, 1994.
7. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T: Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 274:58-65, 1995.
8. Wunder C, Eichelbronner O, Roewer N: Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 53:158-163, 2004.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
10. Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO): diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S118-S126, 2003.
11. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982.
12. Fraunberger P, Pfeiffer M, Cremer P, Holler E, Nagel D, Dehart I, Thein M, Walli AK, Seidel D: Validation of an automated enzyme immunoassay for interleukin-6 for routine clinical use. Clin Chem Lab Med 36:797-801, 1998.
13. Zetterstrom M, Sundgren-Andersson AK, Ostlund P, Bartfai T: Delineation of the proinflammatory cytokine cascade in fever induction. Ann N Y Acad Sci 856:48-52, 1998.
14. Hensler T, Sauerland S, Lefering R, Nagelschmidt M, Bouillon B, Andermahr J, Neugebauer EA: The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20(5):420-426, 2003.
15. de Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, et al: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613, 1997.
16. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608, 1994.
17. Groeneveld AB, Tacx AN, Bossink AW, van Mierlo GJ, Hack CE: Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 106(2):106-115, 2003.
18. Carrol ED, Thomson AP, Hart CA: Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20(1):1-9, 2002.